You're reading the free version. Trader adds the live tape and alerts.
Start tracking
APGE Disposition Disclosure
Dambkowski Carl · SEC Form 4 · Filed Sep 3, 2026
Disposition
Reported value range
Not reported
Dambkowski Carl Chief Medical Officer
APGE
Apogee Therapeutics
APGE
Transaction date
Sep 3, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed same day
APGE daily price context
Close on/before transaction
$135.07
Sep 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 110,665 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001140361-26-035613
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$185.71K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE Current | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 3, 2026 | Not reported |
| Apogee Therapeutics, Inc. APGE | Disposition | Sep 2, 2026 | $185.71K |